Profil
Joris Wiel Jan Wilms formerly worked at Genmab A, as Associate Director-Clinical Development from 2008 to 2010, KLIFO A, as Vice President-Clinical Trial Services from 2010 to 2016, and Y-mAbs Therapeutics, Inc., as Chief Operating Officer & Senior Vice President from 2017 to 2025.
Mr. Wilms received his graduate degree from the University of Groningen.
Anciens postes connus de Joris Wilms
| Sociétés | Poste | Fin |
|---|---|---|
| YMAS THER | Directeur des opérations | 16/09/2025 |
KLIFO A/S
KLIFO A/S Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Corporate Officer/Principal | 01/01/2016 |
| GENMAB A/S | Corporate Officer/Principal | 01/12/2010 |
Formation de Joris Wilms
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Genmab A/S
Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines | Health Technology |
KLIFO A/S
KLIFO A/S Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Commercial Services |
University of Groningen
University of Groningen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Y-mAbs Therapeutics, Inc.
Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer | Health Technology |
















